#GLP1 #PharmaManufacturing #Containment #PotentCompounds #DoverPacs #Biopharma #OEB5 To view or add a comment, sign in Strong conversation and timely perspective
Meanwhile, Geoff Cook, Nooms CEO, noted that selling this product would not interfere with any current regulations, commenting to Reuters that there is a personalized, and there has always been a personalized, exception. Especially as of late, the sale of weight loss drugs by telehealth companies has been a trend
In trials involving patients with type 2 diabetes, it reduced HbA1c (a key marker of long-term blood sugar control) by approximately 1.3 to 1.6 percentage points
They both move you toward better health, but the mechanism, power, and primary outcomes are worlds apart